Treatment discovery and development
The company discovers, develops, and commercializes treatments and therapies, primarily for rare and orphan diseases.
Source: LinkedIn company description · Retrieved October 13, 2026
Emmaus Life Sciences is a biopharmaceutical company focused primarily on rare and orphan diseases.
The company initially focuses its product development efforts on sickle cell disease.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company discovers, develops, and commercializes treatments and therapies, primarily for rare and orphan diseases.
Source: LinkedIn company description · Retrieved October 13, 2026
Its lead product candidate is a pharmaceutical-grade oral L-glutamine treatment that demonstrated positive results in a completed Phase 3 clinical trial for sickle cell anemia and sickle ß0-thalassemia.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Snapshot: September 21, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 21, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.